检测法市场：按产品、技术、用途和最终用户划分 - 2023-2030 年全球预测

全球检测法市场预计将在 2023 年大幅成长至 255.5 亿美元，复合年增长率为 7.17%，预计到 2030 年将达到惊人的 415.7 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球检测法市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.检测法的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球检测法市场的阻碍因素和影响为何？

3. 在预测期内，全球检测法市场需要投资哪些产品/细分市场/用途/领域？

4. 你们在全球检测法市场的竞争策略是什么？

5. 全球检测法市场的技术趋势和法律规范是什么？

6.全球检测法市场主要厂商的市占率为何？

7. 哪些型态和策略措施被认为适合进入全球检测法市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 慢性病和感染疾病的增加以及早期诊断的好处
    • 在分散的医疗服务环境中对快速诊断测试的需求不断增加
    • 扩大多重检测检测法技术在药物研发的应用
  • 抑制因素
    • 与检测法标准化相关的问题
  • 机会
    • 自动化设备和装置数量的技术进步
    • 加速免疫分析在肿瘤学以及药物和酒精检测的应用
  • 任务
    • 政府严格法规场景
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章检测法市场：副产品

• 介绍
• 分析仪
• 消耗品

第7章检测法市场：依技术分类

• 介绍
• 化学发光检测法
• 酶联萤光测定
• 酵素免疫分析法
• 放射免疫分析法

第8章检测法市场：依用途

• 介绍
• 心臟病学
• 内分泌学
• 感染疾病
• 肿瘤学
• 整形外科

第9章检测法市场：依最终用户分类

• 介绍
• 血库
• 诊断实验室
• 医院

第10章美洲检测法市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第11章亚太免疫检测法市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第12章欧洲、中东和非洲检测法市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第13章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

• 讨论指南
• 关于许可证和定价

The Global Immunoassay Market is forecasted to grow significantly, with a projected USD 25.55 billion in 2023 at a CAGR of 7.17% and expected to reach a staggering USD 41.57 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoassay Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoassay Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Analyzer and Consumables. The Consumables is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Chemiluminescence Immunoassay, Enzyme-linked Fluorescence Assay, Enzyme-linked Immunosorbent Assay, and Radioimmunoassay. The Enzyme-linked Immunosorbent Assay is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiology, Endocrinology, Infectious Disease, Oncology, and Orthopedics. The Infectious Disease is projected to witness significant market share during forecast period.

Based on End User, market is studied across Blood Banks, Diagnostics Laboratories, and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoassay Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoassay Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoassay Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoassay Market?

4. What is the competitive strategic window for opportunities in the Global Immunoassay Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoassay Market?

6. What is the market share of the leading vendors in the Global Immunoassay Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoassay Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Immunoassay Market, by Product, 2022 vs 2030
• 4.3. Immunoassay Market, by Technology, 2022 vs 2030
• 4.4. Immunoassay Market, by Application, 2022 vs 2030
• 4.5. Immunoassay Market, by End User, 2022 vs 2030
• 4.6. Immunoassay Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
    • 5.1.1.2. Growing demand for rapid diagnostic tests in decentralized healthcare delivery settings
    • 5.1.1.3. Expanding application of multiplex detection immunoassay technique in drug development
  • 5.1.2. Restraints
    • 5.1.2.1. Issues with immunoassay standardization
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in the number of automated instruments and equipment
    • 5.1.3.2. Accelerating use of immunoassays in oncology and drug & alcohol testing
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulatory scenario
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Immunoassay Market, by Product

• 6.1. Introduction
• 6.2. Analyzer
• 6.3. Consumables

7. Immunoassay Market, by Technology

• 7.1. Introduction
• 7.2. Chemiluminescence Immunoassay
• 7.3. Enzyme-linked Fluorescence Assay
• 7.4. Enzyme-linked Immunosorbent Assay
• 7.5. Radioimmunoassay

8. Immunoassay Market, by Application

• 8.1. Introduction
• 8.2. Cardiology
• 8.3. Endocrinology
• 8.4. Infectious Disease
• 8.5. Oncology
• 8.6. Orthopedics

9. Immunoassay Market, by End User

• 9.1. Introduction
• 9.2. Blood Banks
• 9.3. Diagnostics Laboratories
• 9.4. Hospitals

10. Americas Immunoassay Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Immunoassay Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Immunoassay Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
• FIGURE 2. IMMUNOASSAY MARKET SIZE, 2022 VS 2030
• FIGURE 3. IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 6. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. IMMUNOASSAY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 8. IMMUNOASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. IMMUNOASSAY MARKET DYNAMICS
• FIGURE 10. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. IMMUNOASSAY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED FLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. INDIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. ITALY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. POLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. POLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. QATAR IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. QATAR IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 191. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 192. IMMUNOASSAY MARKET LICENSE & PRICING